Results 291 to 300 of about 2,058,358 (352)

Cardiovascular magnetic resonance‐estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR‐DM‐HF)

European Journal of Heart Failure, EarlyView.
Abstract Aims A cardiovascular magnetic resonance (CMR) approach to non‐invasively estimate left ventricular (LV) filling pressure was recently developed and shown to correlate with invasively measured pulmonary capillary wedge pressure (PCWP). We examined the association between CMR‐estimated PCWP (CMR‐PCWP) and other imaging and biomarker measures of
Joanna Osmanska, Kieran F. Docherty, Colin Berry, Pardeep S. Jhund, Kenneth Mangion, Patrick B. Mark, John J.V. McMurray, Giles Roditi, Naveed Sattar, Mark C. Petrie, Ross T. Campbell, Matthew M.Y. Lee   +11 more
wiley   +1 more source

Prospective registry of heart failure with preserved ejection fraction in México: EDIFICE-Mx. [PDF]

Am Heart J Plus
Araiza-Garaygordobil D, Preciado-Gutierrez OU, Sierra-Lara Martinez JD, Gonzalez-Pacheco H, Gopar-Nieto R, Latapi-Ruiz Esparza X, Hernandez-Pastrana S, Diaz-Herrera BA, Alvarez-Sangabriel A, Jordan-Rios A, Arias-Mendoza A.   +10 more
europepmc   +1 more source

Circulating growth differentiation factor‐15 levels are associated with early echocardiographic signs of diastolic function impairment in the STANISLAS cohort: A 20‐year follow‐up study

European Journal of Heart Failure, EarlyView.
Summary of the study design and key findings. The (+) and (−) signs mean that the variable has a positive or a negative association with growth differentiation factor‐15 (GDF‐15) levels in the fully adjusted model (age, gender, current smoker, body mass index, total cholesterol, systolic blood pressure and N‐terminal pro‐B‐type natriuretic peptide ...
Luca Monzo, Constance Xhaard, João Pedro Ferreira, Guillaume Baudry, Zohra Lamiral, Kevin Duarte, Erwan Bozec, Jean‐Marc Boivin, Olivier Huttin, Patrick Rossignol, Faiez Zannad, Nicolas Girerd   +11 more
wiley   +1 more source

Endothelial deletion of adipose triglyceride lipase protects against heart failure with preserved ejection fraction. [PDF]

JCI Insight
Schwanbeck J, Stahnke M, Eberlein A, Goeritzer M, Schulze A, Pernitsch D, Kolb D, Grabner GF, Bartolomaeus TU, Forslund SK, Gerhardt H, Schiattarella GG, Cocera Ortega L, López-Anguita N, Kershaw EE, Maatz H, Hübner N, Zechner R, Foryst-Ludwig A, Kintscher U.   +19 more
europepmc   +1 more source

Sacubitril/valsartan versus valsartan initiation in patients naïve to renin–angiotensin system inhibitors: Insights from PARAGLIDE‐HF

European Journal of Heart Failure, EarlyView.
Changes in N‐terminal pro‐B‐type natriuretic peptide and assessment of clinical endpoints according to prior exposure to renin–angiotensin system inhibitors in the Pre‐specified substudy of Prospective comparison of ARNI with ARB Given following stabiLization In DEcompensated HFpEF (PARAGLIDE‐HF).
Nina Nouhravesh, Alexander H. Gunn, Derek Cyr, Adrian F. Hernandez, David A. Morrow, Eric J. Velazquez, Jonathan H. Ward, Samiha Sarwat, Kavita Sharma, Kristin M. Williamson, Randall C. Starling, Serge Lepage, Shelley Zieroth, Scott D. Solomon, Robert J. Mentz   +14 more
wiley   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction-The CLIP-HFpEF trial. [PDF]

ESC Heart Fail
Aiad N, du Fay de Lavallaz J, Zhang MJ, Chaikijurajai T, Ye B, Nijjar PS, Lahiri JA, Martin CM, Alexy T, Meyer M.   +9 more
europepmc   +1 more source

A functional role for spontaneously occurring natural anti‐transthyretin antibodies from patients with transthyretin cardiac amyloidosis

European Journal of Heart Failure, EarlyView.
Ortal Tuvali, Michael Fassler, Sorel Goland, Clara Benaim, Sara Shimoni, Jacob George   +5 more
wiley   +1 more source

The Role of Esaxerenone in the Continuum of Heart Failure With Preserved Ejection Fraction: Insights From a Prospective Observational Study. [PDF]

Clin Cardiol
Naruke T, Hashimura-Kakogawa M, Suzuki Y, Ikeda Y, Kitasato L, Nabeta T, Usami-Naruke Y, Ishii S, Oikawa J, Kameda R, Minami Y, Fukaya H, Yuge M, Kawaguchi T, Ako J.   +14 more
europepmc   +1 more source

Clinical Status and Outcome of Japanese Heart Failure Patients With Reduced or Preserved Ejection Fraction Treated With Carvedilol

, 2013
Yoshihiro Mori, Yasuhiro Nishikawa, Fumiaki Kobayashi, Katsutoshi Hiramatsu   +3 more
openalex   +2 more sources

Comorbidity trajectories before and after the diagnosis of heart failure: A UK Biobank cohort study

European Journal of Heart Failure, EarlyView.
Time of diagnosis of comorbidities in relation to heart failure. COPD, chronic obstructive pulmonary disease; MI, myocardial infarction. Abstract Aims Heart failure (HF) is frequently associated with multiple comorbidities. We aimed to define their trajectory of accrual to identify opportunities for disease prevention. Methods and results We identified
Hugo MacGowan, Oliver I. Brown, Michael Drozd, Andrew M.N. Walker, Marilena Giannoudi, Sam Straw, Maria F. Paton, John Gierula, Melanie McGinlay, Kathryn J. Griffin, Klaus K. Witte, Mark T. Kearney, Richard M. Cubbon   +12 more
wiley   +1 more source